Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enact Holdings, Inc. filings document the formal disclosures of a U.S. private mortgage insurance company. Form 8-K reports furnish quarterly and annual operating results, press releases, and financial supplements covering mortgage insurance performance, capital sufficiency, insurance in force, book value, and related financial measures.
The company's regulatory filings also cover proxy governance, board and stockholder voting matters, executive compensation, capital-return actions, stock repurchase arrangements involving Genworth Financial, and financing agreements such as its revolving credit facility. These records describe Enact's public-company governance, capital structure, liquidity arrangements, and material events tied to its mortgage insurance operations.
Enact Holdings, Inc. reported an insider transaction by a director involving deferred stock units linked to company dividends. On 12/11/2025, the director acquired 165 deferred stock units under a director award agreement through reinvestment of a cash dividend paid at $0.21 per share.
Following this transaction, the director beneficially owns a total of 30,543.457 deferred stock units on a direct basis. These deferred stock units become payable in shares of Enact Holdings common stock one year after the director’s service on the board ends.
Enact Holdings, Inc. (ACT) disclosed a Form 4 showing that a company director sold Enact common stock in two transactions. On 11/18/2025, the director sold 2,562 shares of common stock at a weighted average price of $37.411 per share as part of a series of broker-assisted sales ranging from $37.39 to $37.44 per share. On 11/19/2025, the director sold an additional 7,438 shares at $37.39 per share. After these sales, the director reported owning 5,000 shares of Enact common stock directly.
Enact Holdings, Inc. reported Q3 results reflecting steady revenue with softer earnings. Total revenues were $311.5 million versus $309.6 million a year ago, while net income was $163.5 million versus $180.7 million. Diluted EPS was $1.10 compared with $1.15. Net investment income rose to $68.6 million, offset by higher losses incurred of $35.9 million versus $12.2 million.
The balance sheet strengthened as equity reached $5.32 billion and accumulated other comprehensive income improved to $(41.8) million from $(207.5) million at year-end, helped by unrealized gains in the portfolio. Year-to-date, operating cash flow was $538.3 million. Capital returns continued with $105.4 million in share repurchases and $31.0 million in dividends during Q3. The company ended the quarter with $543.6 million in cash and cash equivalents and $744.1 million in long-term borrowings. As of November 3, 2025, common shares outstanding were 144,395,767.
Enact also added protection through reinsurance, including excess-of-loss coverage providing approximately $260 million for policies written in 2026 and $170 million for 2027.
Enact Holdings, Inc. filed a Form 8-K to furnish materials related to its financial results for the quarter ended September 30, 2025. The company provided a press release and a detailed financial supplement to accompany the results.
The information is furnished under Item 2.02 and is not deemed “filed” under Section 18 of the Exchange Act. Exhibits include 99.1 (press release dated November 5, 2025), 99.2 (financial supplement for the quarter), and 104 (cover page Inline XBRL).
Genworth Holdings, Inc. reported the sale of 940,819 shares of Enact Holdings, Inc. common stock on 10/31/2025 at $36.1934 per share. The transaction was effected pursuant to a Share Repurchase Agreement dated April 30, 2025.
Following the sale, Genworth beneficially owns 117,010,462 Enact shares and is identified as a Director and 10% Owner. The filing notes Genworth owns approximately 81% of Enact’s outstanding common stock.
Enact Holdings insider James McMullen reported a grant of 2,599 Restricted Stock Units (RSUs) on 10/01/2025. Each RSU converts 1:1 into common stock and carries a $0 purchase price; after the grant he beneficially owns 2,599 shares directly. The RSUs vest in three equal annual installments beginning 10/01/2026, so the first conversion to shares is scheduled one year after the grant. The filing was signed under power of attorney on 10/03/2025.
Genworth Holdings, Inc. reported the sale of 922,169 shares of Enact Holdings, Inc. (ACT) common stock on 09/30/2025 at a price of $38.3466 per share. The filing states the transaction was effected under a Share Repurchase Agreement dated April 30, 2025, and the per-share price reflects a weighted average price paid by the issuer for third-party purchases under that agreement. After the reported sale, Genworth Holdings beneficially owned 117,951,281 shares, which the filing says represents approximately 81% ownership of Enact outstanding common stock.
Enact Holdings, Inc. disclosed a summary of a new five-year revolving credit facility that matures on the five-year anniversary of closing, September 30, 2030. Borrowings may bear interest at either Term SOFR plus 0.10% plus an applicable margin tied to the company’s Senior Unsecured Rating, or an alternate base rate (ABR) plus an applicable rating-based margin, with a contractual floor on rates.
The facility is unsecured, allows voluntary prepayments without penalty, and charges a commitment fee of 0.175% on unused commitments based on the current rating. It includes customary affirmative and negative covenants plus financial tests: a specified minimum consolidated net worth formula, a maximum debt-to-total-capitalization ratio of 0.35, and compliance with Federal mortgage insurer eligibility requirements. Events of default permit customary remedies including acceleration. The summary is qualified by the full Credit Agreement filed as Exhibit 10.1.
Enact Holdings insider reported grant and settlement of restricted stock units. The Form 4 shows that Evan Stolove, EVP, General Counsel & Secretary, received three separate awards of restricted stock units (RSUs) on 09/08/2025 that will convert 1:1 into common stock. The reported transactions show additions of 17, 27, and 33 RSUs, resulting in beneficial ownership counts of 3,153, 4,979, and 6,047 shares respectively after each reported award. The filing notes vesting schedules for the awards in three equal annual installments beginning on 02/09/2024, 02/16/2025, and 02/21/2026, and that additional RSUs arose from a quarterly dividend reinvestment tied to a $0.21 per share dividend paid 09/08/2025.
Enact Holdings insider award and vesting update: Michael Derstine, EVP and Chief Risk Officer of Enact Holdings (ACT), reported acquisitions of restricted stock units (RSUs) on 09/08/2025 that will convert 1:1 into common stock. Three RSU grants or reinvestments were recorded: 16, 27, and 33 units, each showing a $0 per-share acquisition price and listed as direct ownership. The filings show post-transaction beneficial ownership tallies of 2,965, 4,979, and 6,047 shares respectively. The filing explains RSUs vest in three equal annual installments with commencement dates of February 9, 2024; February 16, 2025; and February 21, 2026. Additional RSUs were credited pursuant to reinvestment terms from a quarterly dividend of $0.21 per share paid on September 8, 2025.